Plain Language Study Results Summaries
What Are Plain Language Study Results Summaries?
Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries (also called layperson summaries, plain language summaries, lay language summaries, simple summaries, and trial results summaries) are intended to make the clinical results of these studies understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.
Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials. For more information about a specific study, please visit ClinicalTrials.gov on the ClinicalTrials.gov Identifier (NCT) link on the study results page.
Category & Conditions: Cancer
Study Phase : 2
Medicine: TALZENNA™(TALAZOPARIB) CAPSULES
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: Ibrance (palbociclib)
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: PF-05221304 + PF-06865571
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: PF-06650833 + ritlecitinib + Xeljanz (tofacitinib)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: PF-06823859
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06886992
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: ritlecitinib (PF-06651600)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: PF-06650833, PF-06700841, PF-06826647
PrintDownloadCategory & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Zavicefta (ceftazidime-avibactam)
PrintDownloadCategory & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Fosmanogepix (PF-07842805)
PrintDownload